Description
Latin name
Hepa-Merz
Release form
Granules for preparation of oral solution
Packaging
10 sachets of 5 g.
Indications
acute and chronic liver diseases accompanied by hyperammonemia
hepatic encephalopathy (latent and severe), incl. as a part of complex therapy for impaired consciousness (precoma or coma)
parenteral nutrition of patients with protein deficiency (as a corrective supplement).
Contraindications
By echnaya failure, severe (serum creatinine> 3 mg / dl 1)
Lactation (breastfeeding)
hypersensitivity to the drug.
Use during pregnancy and lactation
During pregnancy, the use of Hepa-Merz is possible only under strict medical supervision. During treatment, breastfeeding should be stopped
Dosage and administration
Inside, after meals, 1 sachet of granulate, previously dissolved in 200 ml of liquid, 2-3 times a day.
Side effects
Rarely – skin reactions, in some cases – nausea, vomiting.
Overdose
Symptoms: increased severity of side effects.
Storage conditions
At a temperature not exceeding 25 ° C.
Shelf life
5 years.
Deystvuyushtee substance
Ornithine
Conditions of release from drugstores
Without prescription
Dosage
oral solution
Possible product names
HEPA-MERZ 3.0 / 5.0 N10 PACK GRANULES D / R-RA
HEPA-MERZ 3G / 5G. No. 10 GRAN. PACK.
Hepa-Merz gran. VN 3g pack 5g x 10
Hepa-Merz gran. d / prg. r-ra d / p inside 3g / 5g No. 10 Pak.
Hepa-merz gran. package 3 / 5g N10 Germany
Merc Farma GmbH and Ko.KGaA, Germany
